Therapeutic Effect of Chenodeoxycholic Acid in an Experimental Rabbit Model of Osteoarthritis
Osteoarthritis (OA) is a slowly progressive joint disease typically seen in middle-age to elderly people. At present, there is no ideal agent to treat OA. Chenodeoxycholic acid (CDCA) was a principal active constituent from animal bile. However, the therapeutic effect of CDCA on OA severity was larg...
Saved in:
| Main Authors: | Zhao-wei Yan, Ji Dong, Chen-hao Qin, Chun-yang Zhao, Li-yan Miao, Chun-yan He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2015/780149 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Similar Items
-
Significant Reduction of Chenodeoxycholic Acid and Glycochenodeoxycholic Acid in the Elderly with Severe COVID-19
by: Shiyang Liu, et al.
Published: (2025-06-01) -
Multiomics analysis revealed the regulatory role of chenodeoxycholic acid in fatty acid metabolism and lipid homeostasis
by: Lishuang Li, et al.
Published: (2025-07-01) -
Chenodeoxycholic acid triggers gastric mucosal injury by inducing apoptosis and FXR activation
by: Shuaijun Peng, et al.
Published: (2025-01-01) -
Cytotoxic Effect of 6-Ethyl-Chenodeoxycholic Acid and Cabazitaxel on PC-3 Cells
by: M. H. Zalzala, et al.
Published: (2023-02-01) -
Chenodeoxycholic acid triggers gastric mucosal injury by inducing apoptosis and FXR activation.
by: Shuaijun Peng, et al.
Published: (2025-01-01)